Akebia Therapeutics, Inc. (AKBA) Ownership

$2.83

north_east
$0.12 (4.43%)
Day's range
$2.71
Day's range
$2.92

Akebia Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 18.80 M $51.32 M   2.30% 7.16%
VANGUARD GROUP INC 11/07/2025 15.55 M $42.44 M   6.41% 5.92%
STATE STREET CORP 11/14/2025 11.84 M $32.34 M   48.11% 4.51%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 6.18 M $16.89 M   1.82% 2.36%
MORGAN STANLEY 11/14/2025 4.32 M $11.78 M   -19.19% 1.64%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 3.95 M $10.79 M   -5.76% 1.51%
UBS GROUP AG 11/13/2025 3.65 M $9.95 M   470.20% 1.39%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 3.21 M $8.75 M   87.00% 1.22%
CITADEL ADVISORS LLC 11/14/2025 3.19 M $8.70 M   37.48% 1.21%
BIOIMPACT CAPITAL LLC 11/14/2025 2.89 M $7.89 M   0.00% 1.10%
MILLENNIUM MANAGEMENT LLC 11/14/2025 2.86 M $7.80 M   32.07% 1.09%
FRANKLIN RESOURCES INC 11/13/2025 2.68 M $7.32 M   0.48% 1.02%
NORTHERN TRUST CORP 11/14/2025 2.49 M $6.79 M   16.45% 0.95%
AFFINITY ASSET ADVISORS, LLC 11/13/2025 2.45 M $6.69 M   25.64% 0.93%
INVESCO LTD. 11/13/2025 2.40 M $6.55 M   528.13% 0.91%
NUVEEN, LLC 11/12/2025 2.30 M $6.28 M   -15.04% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 2.17 M $5.92 M   189.75% 0.83%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 2.15 M $5.86 M   59.09% 0.82%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 2.00 M $5.46 M   0.00% 0.76%
CITIGROUP INC 11/10/2025 1.92 M $5.23 M   1,324.73% 0.73%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.79 M $4.88 M   61.06% 0.68%
GOLDMAN SACHS GROUP INC 11/14/2025 1.77 M $4.83 M   -55.06% 0.67%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.77 M $4.82 M   100.28% 0.67%
BARCLAYS PLC 11/12/2025 1.18 M $3.22 M   19.88% 0.45%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 1.02 M $2.79 M   -13.56% 0.39%
JPMORGAN CHASE & CO 11/26/2025 994.18 K $2.71 M   -39.85% 0.38%
FMR LLC 11/13/2025 911.82 K $2.49 M   12.02% 0.35%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 869.80 K $2.37 M   25.02% 0.33%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 858.54 K $2.34 M   64.90% 0.33%
SQUAREPOINT OPS LLC 11/14/2025 778.53 K $2.13 M   382.98% 0.30%
BANK OF NEW YORK MELLON CORP 11/03/2025 679.24 K $1.85 M   10.34% 0.26%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 662.53 K $1.81 M   -45.02% 0.25%
FEDERATED HERMES, INC. 11/03/2025 639.37 K $1.75 M   3.57% 0.24%
SWISS NATIONAL BANK 11/13/2025 509.30 K $1.39 M   100.00% 0.19%
AQUATIC CAPITAL MANAGEMENT LLC 11/14/2025 506.91 K $1.38 M   942.31% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 492.33 K $1.34 M   -37.79% 0.19%
RAFFERTY ASSET MANAGEMENT, LLC 11/12/2025 481.87 K $1.32 M   89.75% 0.18%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 442.47 K $1.21 M   3.88% 0.17%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 426.77 K $1.17 M   100.00% 0.16%
RHUMBLINE ADVISERS 11/06/2025 358.67 K $979.16 K   -1.74% 0.14%
JUMP FINANCIAL, LLC 11/13/2025 355.84 K $971.45 K   100.00% 0.14%
AMERICAN CENTURY COMPANIES INC 11/12/2025 349.28 K $953.53 K   288.36% 0.13%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 326.96 K $892.60 K   1,097.43% 0.12%
VICTORY CAPITAL MANAGEMENT INC 11/12/2025 286.39 K $781.83 K   853.60% 0.11%
CREATIVE PLANNING 11/14/2025 282.50 K $771.21 K   -0.29% 0.11%
PRUDENTIAL FINANCIAL INC 11/13/2025 280.56 K $765.92 K   -32.42% 0.11%
MACKENZIE FINANCIAL CORP 11/13/2025 265.28 K $724.21 K   6.71% 0.10%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 11/14/2025 247.70 K $676.22 K   1,543.34% 0.09%
LEGAL & GENERAL GROUP PLC 11/13/2025 245.25 K $669.53 K   953.53% 0.09%
ALLIANCEBERNSTEIN L.P. 11/14/2025 238.93 K $652.28 K   0.00% 0.09%

Akebia Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 239 institutional investors and hedge funds held shares of Akebia Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 18.8 M

VANGUARD GROUP INC: 15.55 M

STATE STREET CORP: 11.84 M

GEODE CAPITAL MANAGEMENT, LLC: 6.18 M

MORGAN STANLEY: 4.32 M

RENAISSANCE TECHNOLOGIES LLC: 3.95 M

47.10% of Akebia Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 146.70 M shares in the last 24 months. This purchase volume represents approximately $415.17 M in transactions.